Metropolis Healthcare has accelerated its acquisition strategy, completing four deals in just ten months, the latest being Kolhapur’s Ambika Pathology Laboratory.

The move aims to strengthen its presence in Western Maharashtra and broaden its reach across India’s growing diagnostics sector. According to Ameera Shah, promoter and executive chairperson of Metropolis, the strategy is designed to consolidate market leadership while creating regional hubs that improve efficiency and patient access. “In Maharashtra, we are already the leading player in most districts. Kolhapur was the only place where we were number two. Ambika Pathology Lab, led by Dr Patel, is a high-quality, technically strong lab. Merging it with Metropolis makes us the clear leader in the region,” she said. Dr Patel will c

See Full Page